Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
2014/03/04 by Peter Gasser, Dominique Holstein, Yvonne Michel +5 · 26 citations
Psychology · Neuroscience · #Psychedelics and Drug Studies #Mental Health Research Topics #Neurotransmitter Receptor Influence on Behavior
paper · doi:10.1097/nmd.0000000000000113
Abstract
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases. Treatment included drug-free psychotherapy sessions supplemented by two LSD-assisted psychotherapy sessions 2 to 3 weeks apart. The participants received either 200 μg of LSD (n = 8) or 20 μg of LSD with an open-label crossover to 200 μg of LSD after the initial blinded treatment was unmasked (n = 4). At the 2-month follow-up, positive trends were found via the State-Trait Anxiety Inventory (STAI) in reductions in trait anxiety (p = 0.033) with an effect size of 1.1, and state anxiety was significantly reduced (p = 0.021) with an effect size of 1.2, with no acute or chronic adverse effects persisting beyond 1 day after treatment or treatment-related serious adverse events. STAI reductions were sustained for 12 months. These results indicate that when administered safely in a methodologically rigorous medically supervised psychotherapeutic setting, LSD can reduce anxiety, suggesting that larger controlled studies are warranted.
Citations
Cited by
- Psychiatry & the psychedelic drugs. Past, present & future
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- Psychedelics
- Existential feelings as a phenomenological framework for psychedelic therapy
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- Psychedelics: The pathway to implementation in the European healthcare systems
- Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
- Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics
- Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
- Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- Phenomenology, Structure, and Dynamic of Psychedelic States
- Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives
- Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies
- The science of psychedelic medicine
- A multi-institutional investigation of psilocybin’s effects on mouse behavior
- Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use
- Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
- Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
- Efficacy and Safety of LSD in the treatment of mental and substance use disorders: A systematic review of randomized controlled trials
- Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
- Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
- With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
- Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Related